Proteomics and disease--the challenges for technology and discovery.
Marko-Varga
György
G
AstraZeneca R&D, Respiratory and Inflammation, Department of Biological Sciences, S-221 87 Lund, Sweden. Gyorgy.Marko-Varga@Astrazeneca.Com
Fehniger
Thomas E
TE
D015415:Biomarkers; D001709:Biotechnology / Q000379:methods / Q000639:trends*; D015180:Electrophoresis, Gel, Two-Dimensional; D023281:Genomics; D006801:Humans; D008967:Molecular Biology / Q000379:methods; D009369:Neoplasms / Q000378:metabolism; D010641:Phenotype; D020543:Proteome; D040901:Proteomics
D015415:Biomarkers; D020543:Proteome